In 2026, several highly anticipated human trials are expected to report results, including those examining:

• Brain health: With 650 participants, one study will be the largest clinical study ever conducted on Mitopure to date

• Immune health: Building on the success of the MitoImmune trial, researchers will be studying Mitopure’s potential as a nutritional supplement to complement immunotherapy in cancer patients.